Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: A systematic review

被引:4
|
作者
Martins, R. -P. [1 ,2 ,3 ,4 ]
Baruteau, A. -E. [1 ,2 ,3 ,4 ]
Treguer, F. [1 ,5 ]
Cesari, O. [1 ]
Carsin-Nicol, B. [6 ]
Langella, B. [6 ]
Leclercq, C. [1 ,2 ,3 ,4 ]
Daubert, J. -C. [1 ,2 ,3 ,4 ]
Mabo, P. [1 ,2 ,3 ,4 ]
机构
[1] CHU Rennes, Serv Cardiol & Malad Vasc, F-35033 Rennes, France
[2] Univ Rennes 1, LTSI, F-35000 Rennes, France
[3] INSERM, U642, F-35000 Rennes, France
[4] INSERM, CIC IT 804, F-35000 Rennes, France
[5] CHU Angers, Serv Cardiol, F-49000 Angers, France
[6] CHU Rennes, Dept Radiol & Imagerie Med, F-35000 Rennes, France
来源
关键词
Magnetic resonance imaging; Pacemaker; Implantable cardioverter defibrillator; Electromagnetic interference; Safety; CARDIAC-PACEMAKERS; IN-VITRO; PERMANENT PACEMAKERS; SAFE PERFORMANCE; 1.5; TESLA; DEPENDENT PATIENTS; MRI; ICDS; 1.5-TESLA; FIELDS;
D O I
10.1016/j.ancard.2009.04.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The presence of a pacemaker or an implantable cardioverter-defibrillator was historically considered a contraindication to magnetic resonance imaging (MRI), due to the risks for both patient and device: reed-switch closure responsible for asynchronous pacing, inhibition of pacing, rapid ventricular pacing, heating on the lead tip or even device displacement ... However, manies recent studies demonstrate that if MRI is crucial for the management of the patient, it can be performed under specific monitoring and scanning conditions and after device reprogramming. The growing implication of device constructors in constructing a MRI safety device will perhaps extend in the future the indications of this imaging modality in implanted patients. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 50 条
  • [22] Radiotherapy in Patients with Pacemakers or implantable Cardioverter-Defibrillators - What to Note?
    Hueltenschmidt, B.
    Hetzel, M.
    Sautter-Bihl, M-L
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 114 - 114
  • [23] TRANSIENT ELASTOGRAPHY IS SAFE IN PATIENTS WITH PACEMAKERS AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    Schoelzel, F.
    Linzbach, S.
    Seeger, F.
    Bojunga, J.
    Fichtlscherer, S.
    Rey, J.
    Herrmann, E.
    Zeiher, A. M.
    Zeuzem, S.
    Friedrich-Rust, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S513 - S513
  • [24] Determining the Risks of Magnetic Resonance Imaging at 1.5 Tesla for Patients With Pacemakers and Implantable Cardioverter Defibrillators
    Cohen, Jennifer D.
    Costa, Heather S.
    Russo, Robert J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11): : 1631 - 1636
  • [25] How much heating is associated with magnetic resonance imaging in patients with pacemakers and implantable cardioverter defibrillators?
    Steven Mason
    Jon-David Ethington
    Raymond O McCubrey
    Allison E Tonkin
    Jeffrey L Anderson
    Journal of Cardiovascular Magnetic Resonance, 16 (Suppl 1)
  • [26] Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices
    Corzani, Alessandro
    Ziacchi, Matteo
    Biffi, Mauro
    Allaria, Luca
    Diemberger, Igor
    Martignani, Cristian
    Bratten, Tara
    Gardini, Beatrice
    Boriani, Giuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (10) : 704 - 714
  • [27] Hemodynamic response and safety of vasodilator stress cardiovascular magnetic resonance in patients with permanent pacemakers or implantable cardioverter-defibrillators
    Miller, Lauren
    Airapetov, Sergei
    Pillai, Ajay
    Kalahasty, Gautham
    Ellenbogen, Kenneth A.
    Hundley, W. Gregory
    Trankle, Cory R.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (10) : 2127 - 2135
  • [28] Use of implantable cardioverter-defibrillators in athletes: A systematic review
    Almeida, Ricardo Liz
    Providencia, Rui
    Goncalves, Lino
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (06) : 410 - 418
  • [29] Management of infected pacemakers and implantable cardioverter-defibrillators - Reply
    Post, J. J.
    Alexopoulos, C.
    Jones, P. D.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (07) : 510 - 510
  • [30] Transvenous lead performance of implantable cardioverter-defibrillators and pacemakers
    Mori, Hitoshi
    Kato, Ritsushi
    Ikeda, Yoshifumi
    Tsutsui, Kenta
    Hoya, Hiroki
    Tanaka, Sayaka
    Iwanaga, Shiro
    Nakano, Shintaro
    Muramatsu, Toshihiro
    Sumitomo, Naokata
    Matsumoto, Kazuo
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (03): : 481 - 489